Apontis Pharma AG • APPH
Capital at risk.
About Apontis Pharma AG
Ticker
Trading on
ISIN
Industry
Sector
CEO
Headquarters
Employees
Website
Metrics
Market cap
P/E ratio
EPS
Dividend Yield
Beta
Forward P/E ratio
EBIDTA
Ex dividend date
Price & volume
Market cap
Average daily volume
90-day return
30-day return
7-day return
Dividends
Dividend per share
Dividend yield
Forward dividend per share
Forward dividend yield
Payout ratio
Valuation
P/E ratio
Forward P/E
PEG ratio
Trailing P/E
Price to sales
Price to book
Earnings
EPS
EPS estimate (current quarter)
EPS estimate (next quarter)
EBITDA
Revenues (TTM)
Revenues per share (TTM)
Technicals
Beta
52-week High
52-week Low
50-day moving average
200-day moving average
Short ratio
Short %
Management effectiveness
ROE (TTM)
ROA (TTM)
Profit margin
Gross profit margin
Operating margin
Growth
Quarterly earnings growth (YoY)
Quarterly revenue growth (YoY)
Share stats
Outstanding Shares
Float
Insiders %
Institutions %
Financial Performance
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.
Build your future fund today!
Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!
Capital at risk.
FAQs
Apontis Pharma AG shares are currently traded for undefined per share.
Apontis Pharma AG currently has 8.5M shares.
No, Apontis Pharma AG doesn't pay dividends.
Apontis Pharma AG 52 week high is €11.90.
Apontis Pharma AG 52 week low is €5.96.
Apontis Pharma AG 200-day moving average is €8.99.
The CEO of Apontis Pharma AG is Bruno Wohlschlegel.
Apontis Pharma AG has 177 employees.
The market cap of Apontis Pharma AG is €98.6M.
The current P/E of Apontis Pharma AG is null.
The EPS of Apontis Pharma AG is -€0.83.
The PEG Ratio of Apontis Pharma AG is null.